Journey Medical Corporation (DERM): A Bull Case Theory

We came across a bullish thesis on Journey Medical Corporation (DERM) on Substack by The 10x Radar. In this article, we will summarize the bulls’ thesis on DERM. Journey Medical Corporation (DERM)’s share was trading at $4.98 as of Feb 19th. DERM’s trailing and forward P/E were 39.77 and 100 respectively according to Yahoo Finance.

A dermatologist in an exam room, observing a positive response to therapy for inflammatory bowel diseases, acne, psoriasis, asthma, allergies, or bacterial...